Free Newsletter
NJ puts $150M stem cell research center on hold
New Jersey's planned $150 million stem cell research center has been put on ice as state leaders ponder how to proceed in the wake of voters' rejection of a $450 million stem cell initiative last year. According to the Star-Ledger, state officials had earlier insisted that they would go ahead and complete construction of the 18-story facility. But Governor Jon Corzine told reporters that the state's once ambitious plans for stem cell research are on hold until officials get a better assessment of their options.
"I'd like to have a director and I'd like to see what our options are on making sure that New Jersey continues to be the leader, or among the leaders on biotech research--particularly as it relates to stem cells," Corzine said. "And then we'll work together on our rollout of what our plans are."
- read the story in the Star-Ledger
Related Articles:
NJ officials want to expand biopharma biz
NJ stem cell initiative shot down at the polls
NJ lawmakers back $270M stem cell program
In New Jersey, biotech industry is booming
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: